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The dynamics of the inductive effects of MC and TCDD upon rat liver microsomal benzpyrene hydroxylase 
and the main properties of the de novo synthesized hemoproteins have been compared. The inadequacy 
of expression of the enzyme activity per total cytochrome P-448 content has been established. It was con- 
cluded that TCDD microsomes have a relatively low content of benzpyrene hydroxylase with a higher 
molecular activity than the enzyme from MC microsomes. 
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1. INTRODUCTION 
Among hundreds of xenobiotics, which are in- 
ducers of the microsomal monooxygenases, TCDD 
takes a particular place. This xenobiotic is the most 
potent inducer of the MC type so far known and 
has therefore been used widely in studies on the 
key steps of intracellular reception of an inducer 
and expression of structural genes of aromatic 
hydrocarbon hydroxylases in the livers of mice, 
rats and rabbits [ 1,2]. This study has been under- 
taken because the usage of TCDD and MC as 
typical inducers led to contradictory results con- 
cerning the similarity molecular mechanisms of in- 
duction and the synthesized forms of cytochrome 
P-450 [3,4]. The results of a reappraisal of the 
dynamics of induction by TCDD and MC of benz- 
pyrene hydroxylases, and of the catalytic, spectral, 
immunochemical and electrophoretic properties of 
Abbreviations: MC, 3-methylcholanthrene; TCDD, 
2,3,7,8-tetrachlorodibenzo-p-dioxin, SDS-PAGE, SDS- 
polyacrylamide gel electrophoresis 
the de novo synthesised hemoproteins are 
presented here. 
2. MATERIALS AND METHODS 
Chemicals used were purchased from the follow- 
ing sources: MC, Serva; 3,4-benzpyrene, Fluka; 
NADPH, Boehringer; L-[l-14C]leucine, Amer- 
sham. Reagents for SDS-PAGE were from Phar- 
macia. TCDD was a generous gift from Dr Daniel 
Nebert (NICHHD, Bethesda). 
Male Wistar rats (50 g) were treated with either 
MC (40 mg/kg) or TCDD (25 pg/kg) 16 h before 
killing. The rats were also injected i.p. with L- 
[l-14C]leucine (500&i) 4 and 8 h before killing. In 
other experiments the rats were treated with MC or 
TCDD for 72 h beforehand. 
Microsomes were prepared from livers by con- 
ventional differential centrifugation. Cytochrome 
P-450 (P-448) and protein were determined as 
described [5,6]. Benzpyrene hydroxylase activity 
was determined fluorimetrically as in [7]. All spec- 
tral measurements were performed with a Hitachi 
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556 spectrophotometer and MPF-4 spectroflu- 
orimeter. 
SDS-PAGE was carried out on 7,5-15% gra- 
dient gels according to Laemmli [8] with GE-2/4 
slab gel apparatus (Pharmacia). Fluorography of 
PAGE slabs was performed as described by 
Chamberlain [9]. Radioactivity was determined 
with a Mark-III liquid scintillation spectrometer. 
Cytochrome P-448 was purified from the MC 
microsomes [IO] to a concentration of 16-18 nmol 
per mg protein and its homogeneity verified using 
SDS-PAGE. Antibodies against isolated 
cytochrome P-448 were obtained from the sera of 
rabbits as described in [7]. Rocket immunoelec- 
trophoresis of liver microsomes for specific quan- 
titation of benzpyrene hydroxylase was performed 
according to [Ill with Multiphor 2117 (LKB). 
Metabolism of 3,4-benzpyrene in the presence of 
antibodies was determined as in [7]. 
3. RESULTS AND DISCUSSION 
The main results obtained are presented in table 
1 from which it can be seen that 16 h after injection 
of MC or TCDD into rats there was no increase in 
the total microsomal cytochrome content, nor shift 
of the Na2S204 CO peak to 448 nm. Nevertheless, 
at the same time benzpyrene hydroxylase activity 
increased significantly. This fact has been 
acknowledged in earlier experiments with mice 
pretreated with MC or TCDD 1121. Table 1 shows 
that in MC microsomes the K, for 3,4-benzpyrene 
decreased to the level characteristic of maximal in- 
duction. The specific hemoprotein form amounts 
to l/3 of the total cytochrome content, as deter- 
mined by rocket immunoelectrophoresis using an- 
tibodies against MC cytochrome P-448 (56 kDa). 
However, it is precisely this particular form of the 
cytochrome that catalyses metabolism of 
Table 1 
A comparison of inducing effects of MC and TCDD upon rat liver microsomal benzpyrene hydroxylases 
Parameters determined 
MC 
Time after inducer injection (h) 
16 72 
TCDD MC TCDD 
Control 
group 
(A) Hemoprotein content 
1. Total content 
(nmol/mg protein) 
2. Content of specific form 
(nmol/mg protein) 
3. Position of CO peak (nm) 
(B) Benzpyrene hydroxylases 
1. K, for 3,4-benzpyrene (JxM) 
2. Total activity (nmol/min) 
-per mg protein 
-per nmol total cytochrome 
3. Specific activity (nmol/min) 
-per mg protein 
-per nmol specific form 
0.55 +0.02 
0.198 + 0.007 
(36Y 
448.5 
0.39 +0.04 
2.85 +0.15 
5.18 kO.085 
2.71 t-O.14 
(95)b 
13.69 & 0.22 
0.59 kO.02 
0.0235 f 0.005 
(4) 
449 
0.54 kO.07 
1.00 20.06 
1.70 -to.04 
0.82 kO.05 
(82) 
34.86 k 1.38 
1.06+0.02 
0.90+0.02 
(85) 
448 
0.40+0.02 
3.45 + 0.20 
3.25 +0.13 
3.28kO.19 
(95) 
3.64eO.13 
(C) In vivo incorporation of [‘4C]- 
leucine into microsomes (Yo) 450 290 n.d. 
aPercent of total cytochrome content 
bPercent of inhibition by antibodies against MC cytochrome P-448 
clOO% = 133 cpm/mg protein 
Values are means + SE from 3-5 experiments 
226 
0.87 1- 0.02 0.53 f 0.01 
0.209 2 0.005 - 
(24) (<3) 
448 450 
0.37 + 0.03 0.53 ?- 0.03 
2.90+0.18 0.23 of: 0.01 
3.33kO.13 0.43 * 0.01 
2.81 +0.17 - 
(97) 
13.46+0.52 - 
n.d. 100’ 
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3,4-benzpyrene in MC microsomes. This was 
evinced by almost complete inhibition of the reac- 
tion by antibodies against the purified MC 
cytochrome P-448. 
SDS-PAGE of MC and TCDD microsomes 
showed two very faint bands in the region of 
migration of the hemoproteins (48-58 kDa) (fig. 1). 
Fluorography of the gels after SDS-PAGE separa- 
tion of the [‘4C]leucine-labeled MC and TCDD 
microsomes revealed that these bands belong to the 
de novo synthesized polypeptides of 53 and 56 kDa 
(fig.2). These bands were lacking in the prepara- 
tions of control microsomes. These two hemopro- 
teins isolated and purified from MC microsomes 
were both registered spectrally as cytochrome 
P-448 but only the latter posessed high benzpyrene 
hydroxylase activity in a reconstituted system as 
well as cross-reactivity with homologous anti- 
bodies. 
Unlike the MC microsomes, the K, for 
3,4-benzpyrene in the liver microsomes prepared 
16 h after injection of TCDD did not exceed that 
in control microsomes. In the TCDD microsomes 
the rate of the benzpyrene hydroxylation reaction 
calculated per nmol total hemoprotein was 
relatively low (see table 1). However, it should be 
Fig. 1. SDS N-PAGE in gradient (7.5- -15.0%) gels of 
micl rosomal protein (25 fig) from contr .ol (C), and MC- 
and TCDD -treated rat: 5. Standar ,d prc stein mixture (S) 
contained: I, phosphorylase b (94 kDa); II, albumin (67 
kDa); III, ovalbumin (43 kDa); IV, carbonic anhydrase 
(30 kDa); V, cY-lactalbumin (14.4 kDa). 
I 
II 
IV 
V 
s C MC TCDD 
Fig 
C MC TCDD S 
.2. Fluorogram of SDS-PAGE slab . . 
I 
II 
IV 
V 
after elec- 
trophoresis of [“C]leucine-labeled microsomal proteins 
(25 ,ug) from control (C), and MC- and TCDD-treated 
rats. The mixture of standard proteins was as in fig.1. 
227 
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emphasized that 16 h TCDD microsomes contain 
an extremely small amount of the specific 
hemoprotein form with benzpyrene hydroxylase 
activity. Therefore, calculation of the activity per 
nmol of this specific form of the hemoprotein has 
revealed a considerably higher turnover number of 
the enzyme in TCDD microsomes than that of 
cytochrome P-448 in MC microsomes. The same 
results were also obtained with 7-ethoxyresorufin 
as a substrate (not shown). The decisive contribu- 
tion of this form of the cytochrome to hydroxyla- 
tion of 3,4-benzpyrene was proved by inhibitory 
analysis using homologous antibodies. 
72 h after injection of TCDD into rats the liver 
microsomes displayed the characteristic blue shift 
of the maximum CO peak and an increase in the 
total cytochrome P-448 content. There was also a 
6-fold increase in benzpyrene hydroxylase when 
compared with the level at 16 h but it still com- 
prised only 24% from the total cytochrome con- 
tent. Therefore, the activities of the enzyme 
calculated per nmol total cytochrome content are 
the same in both MC and TCDD microsomes. 
However, when the activity is calculated per nmol 
specific hemoprotein form determined im- 
munochemically, then benzpyrene hydroxylase in 
TCDD microsomes is 3.7-fold more active than in 
MC microsomes. 
The molecular activity and K, values for the 
substrate are similar in 72 h TCDD microsomes 
and 16 h MC microsomes. The supposition about 
the slower rate of biosynthesis of the enzyme in 
rats pretreated with TCDD was confirmed in the in 
vivo experiments with pulses of [r4C]leucine. It 
may be seen from table 1 that incorporation of the 
label into TCDD microsomes was 1.5fold less ef- 
fective than into MC microsomes. 
Thus, only direct comparison of the inductive 
effects of MC and TCDD has elucidated the fact 
that treatment of Wistar rats with TCDD induces 
the synthesis of benzpyrene hydroxylase which 
represents only a minor part of the total 
microsomal cytochrome but has high molecular 
activity. 
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